Valuation Abbott Laboratories (Pakistan) Limited

Stocks

End-of-day quote Pakistan S.E. 2026-10-20			5-day change	1st Jan Change
935.61 ^PKR	-1.28%		+0.80%	-10.91%

08-28	Abbott Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
04-27	Abbott Laboratories Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	121,187	102,809	91,597	-	-
Change	-	-15.16%	-10.91%	-	-
Enterprise Value (EV)	121,187	102,809	91,597	91,597	91,597
Change	-	-15.16%	-10.91%	0%	0%
P/E	23.2x	-	-	-	-
PBR	-	-	2.45x	2.04x	1.76x
PEG	-	-	-	-	-
Capitalization / Revenue	-	-	-	-	-
EV / Revenue	-	-	-	-	-
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	40	38	46	48
Rate of return	-	3.81%	4.06%	4.92%	5.13%
EPS ²	53.46	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales	-	-	-	-	-
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	5,234	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	1,237.86	1,050.14	935.61	935.61	935.61
Nbr of stocks (in thousands)	97,900	97,900	97,900	-	-
Announcement Date	2/20/25	3/16/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES (PAKISTAN) LIMITED	-	-	-	4.01%	335M
ELI LILLY AND COMPANY	35.75x	12.79x	26.94x	0.55%	1,106B
JOHNSON & JOHNSON	37.14x	6.26x	17.62x	2.1%	612B
ABBVIE INC.	36.08x	8.31x	17.14x	2.43%	500B
ROCHE HOLDING AG	20.6x	4.98x	12.38x	2.63%	367B
MERCK & CO., INC.	104.7x	5.86x	25.15x	2.37%	354B
NOVARTIS AG	21.05x	5.51x	13.55x	2.9%	286B
ASTRAZENECA PLC	21.56x	4.37x	12.5x	2.02%	256B
AMGEN INC.	26.98x	6.96x	12.46x	2.37%	230B
GILEAD SCIENCES, INC.	-44.72x	6.87x	26.59x	2.15%	190B
Average	28.79x	6.88x	18.26x	2.36%	390.05B
Weighted average by Cap.	34.40x	8.11x	19.89x	1.85%